Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Synergy Rx vs Virta Health

Synergy Rx
Graded #41

Higher grade

vs+16.5
Virta Health
Graded #337

Lower grade

The verdict

Synergy Rx takes it — 76.2/100 to 59.7/100.

Synergy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Brand Wegovy, Ozempic or Mounjaro when clinically appropriate, with unlimited round-the-clock clinical contact.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSynergy Rx +17
62
45
Dose & formulationSynergy Rx +37
88
51
Clinical oversightSynergy Rx +15
92
77
Labs & monitoringVirta Health +5
66
71
FulfillmentSynergy Rx +13
78
65
Contract termsSynergy Rx +13
68
55
Synergy Rx · left barVirta Health · right bar

The numbers

MetricSynergy RxVirta Health
WeighScore76.2/10059.7/100
GradeCC
Scorecard rank#41#337
SemaglutideFrom $199/moNot disclosed
TirzepatideFrom $349/moNot disclosed
CoverageNot disclosedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Synergy Rx

Graded #41 · C

Strengths

  • Prescribes FDA-approved brand Wegovy, Ozempic and Mounjaro when clinically appropriate
  • Unlimited appointments, unlimited messaging and 24/7 access to a dedicated clinical team
  • $100 welcome credit at checkout, and FSA/HSA eligible

Where it loses points

  • Publishes no GLP-1 price anywhere on its own site
  • At $349/mo tirzepatide sits roughly $100 above the compounded median we track
  • Does not publish which states it serves
  • No published cancellation or refund terms
Virta Health

Graded #337 · C

Strengths

  • Offers a Responsible Prescribing track with optimized GLP-1 use
  • Clinically monitored medication off-ramp toward nutrition therapy
  • Nutrition-first model shown to rival GLP-1 weight loss (about 13% at 1 year)
  • Provided at no cost to members through employers and health plans
  • Strong evidence base for diabetes reversal and metabolic health

Where it loses points

  • Primarily a nutrition program; GLP-1s are a secondary track
  • Distributed via employers and health plans, no direct cash-pay
  • Deliberately discourages GLP-1 use for most members
  • GLP-1 access depends on the specific program the plan selects

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard